Ningbo Menovo Pharmaceutical Co., Ltd.

SSE:603538.SS

15.24 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income 66.80711.586367.614158.07173.055160.8105.06249.95385.12381.77378.49169.00560.6169.335
Depreciation & Amortization 133.751118.478101.76398.94485.01863.67449.85232.40831.97929.5925.9419.5198.3970
Deferred Income Tax 0-8.931-40.23-21.00618.356-7.615-9.5131.448000000
Stock Based Compensation 0024.6955.27110.88220.3367.6420000000
Change In Working Capital -200.215-208.491-85.44-62.182-2.772-100.446-115.297-13.081-16.15520.174-42.132000
Accounts Receivables -91.692-98.836-213.625-50.864-28.23-17.577-98.248-23.352-34.29975.22-55.117000
Inventory -185.427-49.558-182.987-124.676-82.97-113.082-70.705-2.95314.45417.829-28.517000
Accounts Payables 0-51.166351.402134.36463.33937.82763.16911.777000000
Other Working Capital 76.904-8.931-40.23-21.00645.089-7.615-44.592-10.128-30.6092.345-13.616000
Other Non Cash Items 97.19596.491-91.44941.531-32.92743.0036.97910.87316.2971.88112.915-69.005-60.61-69.335
Operating Cash Flow 97.5379.133276.952220.629251.611179.75246.59580.154117.244133.41875.215149.20738.1050
Investing Activities:
Investments In Property Plant And Equipment -179.402-219.545-571.618-529.892-311.741-328.069-299.588-86.217-108.841-61.56-46.141-75.435-81.724-159.712
Acquisitions Net 0105.944487.931-47.1040.4842.741-45.1451.293.8245.003000.8880.29
Purchases Of Investments -467.543-1,197.861-713.936-1,640.45-865-690.836-773.015-600.339-35-69.647-9.07-29.368-7.35-124.976
Sales Maturities Of Investments 544.993975.121902.51,562.169693.525639.972789.449293.17304.974001.92948.747
Other Investing Activites 2.16612.735-54.61752.0253.76824.9912.091-29.526.97762.20543.75174.69-45.124-10.024
Investing Cash Flow -99.786-323.60650.259-603.252-478.964-351.201-326.208-421.593-116.864-59.025-11.46-30.113-131.381-245.675
Financing Activities:
Debt Repayment 11.8292.4419.4769.675193.69257.291336.72788.02937-129-5.65-37.7269.4138.76
Common Stock Issued 000.0970.1710.5310.5940-15.893000000
Common Stock Repurchased 0-1.118-0.097-0.171-0.531-0.59400000000
Dividends Paid -22.712-59.242-30.263-13.833-16.445-29.811-39.064-4.362-2.648-1.833-10.038-27.705-10.725-10.539
Other Financing Activities 43.27821.673-147.807587.47914.30892.48186.338387.507-1.462-4.5940-10.22-7.13416.038
Financing Cash Flow 32.38654.871-178.456583.149138.43898.998384.002471.17332.89-135.427-15.688-75.64551.55144.26
Other Information:
Effect Of Forex Changes On Cash 8.841-3.45414.631-2.293-2.0432.429-1.545-3.6053.3228.2590000
Net Change In Cash 38.978-263.056163.387198.233-90.958-70.022102.844126.12936.592-52.77448.06743.45-41.725-79.749
Cash At End Of Period 312.948273.97537.025373.638174.55265.508335.53232.686106.55869.966122.7474.67331.22372.948